Composition

"active ingredient: ceftazidime;

1 vial contains ceftazidime (in the form of ceftazidime pentahydrate) 1.0 g;

excipient: sodium carbonate anhydrous."

Indications

Treatment of the following infections in adults and children, including newborns:

- hospital-acquired pneumonia;

- respiratory tract infections in patients with cystic fibrosis;

- bacterial meningitis;

- chronic otitis media;

- malignant otitis externa;

- complicated urinary tract infections;

- complicated skin and soft tissue infections;

- complicated infections of the abdominal cavity;

- bone and joint infections;

- dialysis-related peritonitis in patients undergoing continuous outpatient peritoneal dialysis.

Treatment of bacteremia that occurs in patients as a result of any of the above infections.

Ceftazidime may be used to treat patients with neutropenia and fever resulting from a bacterial infection.

Ceftazidime can be used for the prevention of urinary tract infections during prostate surgery (transurethral resection).

When prescribing ceftazidime, its antibacterial spectrum should be taken into account, which is directed mainly against gram-negative aerobes (see sections ""Precautions for Use"" and ""Pharmacological properties"").

Ceftazidime should be used in combination with other antibacterial agents if it is expected that a number of microorganisms causing the infection do not fall within the spectrum of ceftazidime.

The drug should be prescribed in accordance with the existing official guidelines for the use of antibacterial agents.

Contraindications

Hypersensitivity to ceftazidime or other components of the drug.

Hypersensitivity to cephalosporin antibiotics.

History of severe hypersensitivity (e.g. anaphylactic reactions) to other beta-lactam antibiotics (penicillins, monobactams and carbapenems).

Routes of Administration and Dosage Take orally.

Eurozidime should be administered by intravenous injection or infusion or by deep intramuscular injection. The recommended sites for intramuscular injection are the upper outer quadrant of the gluteus maximus muscle or the lateral thigh.

Ceftazidime solutions can be injected directly into a vein or into an intravenous infusion system if the patient is receiving fluids parenterally.

The dose depends on the severity of the disease, susceptibility, location and type of infection, as well as the patient's age and renal function.

Acquired resistance to an antibiotic varies from region to region and may change over time, and may differ significantly for certain strains. It is advisable to use local (local) data on antibiotic susceptibility, especially in the treatment of severe infections.

 

This information about medicinal products, including prescription drugs, is intended for information purposes only and is not a guide for self-diagnosis and/or treatment.
The use of medicinal products is possible only as prescribed by a physician and after prior consultation with him/her. Self-medication can be harmful to your health.